Skip to content
No results
  • Home
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
  • About Us
  • Contact Us
  • About Us
  • Contact Us
The Pharma Data
  • News
  • Press Releases
  • Business
  • Technology
  • Research
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Regulatory

City of Hope Appoints New Presidents for Cancer Centers in Arizona and Atlanta

  • The Pharma Data
  • October 7, 2026

City of Hope Names Laurie Sicaeros and Melissa Childress to Lead Cancer Centers in Arizona and Atlanta City of Hope, one of the largest and most advanced cancer research and…

Read MoreCity of Hope Appoints New Presidents for Cancer Centers in Arizona and Atlanta
  • Press Releases

Nitto Avecia Receives Third Consecutive FDA Inspection with No Action Indicated

  • The Pharma Data
  • October 7, 2026

Nitto Avecia’s Milford Facility Receives FDA No Action Indicated Classification Following cGMP Inspection Nitto Avecia, a contract development and manufacturing organization (CDMO) specializing in oligonucleotide therapeutics, announced that the U.S.…

Read MoreNitto Avecia Receives Third Consecutive FDA Inspection with No Action Indicated
  • Regulatory

Shape Memory Medical Receives ANVISA Approval for IMPEDE Embolization Plug Family in Brazil

  • The Pharma Data
  • October 7, 2026

Shape Memory Medical Receives ANVISA Authorization for IMPEDE Embolization Plug Portfolio in Brazil Shape Memory Medical Inc., a medical technology company developing volume-expanding shape memory polymer solutions for endovascular embolization,…

Read MoreShape Memory Medical Receives ANVISA Approval for IMPEDE Embolization Plug Family in Brazil
  • Regulatory

NeuroLife Appoints Christopher Coburn and Matthew Thomas to Board

  • The Pharma Data
  • October 7, 2026

NeuroLife Appoints Christopher Coburn and Matthew Thomas to Board as Company Advances Neurotechnology Platform Appoints®, a neurotechnology company focused on developing non-invasive solutions to help restore function and independence for…

Read MoreNeuroLife Appoints Christopher Coburn and Matthew Thomas to Board
  • Press Releases

Exthymic Secures Up to $25M ARPA-H Contract for Hospital-Based Cell Therapy Production

  • The Pharma Data
  • October 6, 2026

Exthymic Receives Up to $25 Million ARPA-H Award to Advance LITTLESTAR Cell Therapy Manufacturing Device Exthymic Corporation, a biotechnology company developing technologies designed to expand access to engineered cell therapies,…

Read MoreExthymic Secures Up to $25M ARPA-H Contract for Hospital-Based Cell Therapy Production
  • News

GE HealthCare to Acquire SOFIE Biosciences to Expand U.S. PET Radiopharmaceutical Supply

  • The Pharma Data
  • October 6, 2026

GE HealthCare to Acquire SOFIE Biosciences for $945 Million to Expand U.S. Radiopharmaceutical Manufacturing GE HealthCare (Nasdaq: GEHC) has announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based…

Read MoreGE HealthCare to Acquire SOFIE Biosciences to Expand U.S. PET Radiopharmaceutical Supply
  • Research

Epicrispr Reports Positive Six-Month EPI-321 Data in FSHD Patients

  • The Pharma Data
  • October 6, 2026

Epicrispr Reports Six-Month Clinical Data for EPI-321 Gene Therapy in FSHD Epicrispr Biotechnologies, a clinical-stage biotechnology company developing epigenetic therapies, has announced updated six-month clinical data from the ongoing first-in-human…

Read MoreEpicrispr Reports Positive Six-Month EPI-321 Data in FSHD Patients
  • Industry Updates

BioCentury Grand Rounds Heads to Houston for Sixth Investor and Executive Meeting

  • The Pharma Data
  • October 6, 2026

BioCentury Opens Registration for 2027 Grand Rounds Conference in Houston BioCentury has announced that registration is now open for the sixth edition of BioCentury Grand Rounds: US, a translational science-focused…

Read MoreBioCentury Grand Rounds Heads to Houston for Sixth Investor and Executive Meeting
  • News

Catalent Launches U.S. Gene-to-Drug Substance Program for Complex Molecules

  • The Pharma Data
  • October 6, 2026

Catalent Launches Accelerated U.S. Gene-to-Drug Substance Program for Complex Biologics Catalent, Inc., a global contract development and manufacturing organization (CDMO) serving the biopharmaceutical industry, has announced the U.S. launch of…

Read MoreCatalent Launches U.S. Gene-to-Drug Substance Program for Complex Molecules
  • Press Releases

I2Pure Strengthens Leadership and Scientific Team with Three Key Hires

  • The Pharma Data
  • October 6, 2026

I2Pure Expands Leadership and Scientific Team to Support Molecular Iodine Manufacturing and Research Growth I2Pure Corp., a biotechnology company focused on patented molecular iodine (I₂) technology for antimicrobial and antiseptic…

Read MoreI2Pure Strengthens Leadership and Scientific Team with Three Key Hires
  • Research

Alliance Foundation Trials and Natera Launch Phase III NAVIGATE Trial in Breast Cancer

  • The Pharma Data
  • October 6, 2026

Alliance Foundation Trials and Natera Launch Phase III NAVIGATE Trial to Evaluate MRD-Guided Breast Cancer Treatment Alliance Foundation Trials, LLC (AFT), a national organization focused on advancing innovative and practice-changing…

Read MoreAlliance Foundation Trials and Natera Launch Phase III NAVIGATE Trial in Breast Cancer
  • Business

Bayer to Invest $2.2 Billion in New U.S. Manufacturing Site

  • The Pharma Data
  • October 3, 2026

Bayer Plans $2.2 Billion Pharmaceutical Manufacturing Investment in Ohio Bayer has announced plans to invest approximately $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, marking one…

Read MoreBayer to Invest $2.2 Billion in New U.S. Manufacturing Site
PrevNext

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Tenpoint Therapeutics Submits New Drug Application to Health Canada for Adult Presbyopia TreatmentNovember 21, 2026
  • CEL-SCI’s Multikine® Granted Saudi FDA NADR Designation, Advancing Commercialization PlansNovember 21, 2026
  • Fujifilm Enhances ECHELON Synergy 1.5T MRI with ZeroHelium Technology and Dockable Patient TableNovember 21, 2026
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.